| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperoxia | 5 | 2023 | 129 | 2.430 |
Why?
|
| Bronchopulmonary Dysplasia | 4 | 2023 | 190 | 2.170 |
Why?
|
| Lung Injury | 3 | 2023 | 124 | 2.170 |
Why?
|
| Receptors, Progesterone | 11 | 2018 | 879 | 1.510 |
Why?
|
| Mammary Glands, Animal | 12 | 2019 | 482 | 1.290 |
Why?
|
| CA-125 Antigen | 1 | 2025 | 15 | 0.970 |
Why?
|
| Carcinoma, Medullary | 1 | 2025 | 15 | 0.970 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2025 | 237 | 0.960 |
Why?
|
| Transcriptome | 5 | 2024 | 937 | 0.840 |
Why?
|
| Kidney Neoplasms | 2 | 2025 | 431 | 0.830 |
Why?
|
| Gene Expression Regulation | 10 | 2024 | 2538 | 0.760 |
Why?
|
| Gonadal Hormones | 1 | 2021 | 3 | 0.760 |
Why?
|
| Sex Chromosomes | 1 | 2021 | 34 | 0.750 |
Why?
|
| Mice, Inbred C57BL | 9 | 2024 | 4431 | 0.730 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2021 | 91 | 0.710 |
Why?
|
| Mice | 35 | 2024 | 17746 | 0.670 |
Why?
|
| Biomarkers, Tumor | 2 | 2025 | 1465 | 0.640 |
Why?
|
| Tuberculosis | 5 | 2024 | 519 | 0.640 |
Why?
|
| Animals | 47 | 2025 | 34184 | 0.590 |
Why?
|
| Liver Neoplasms | 4 | 2024 | 1319 | 0.580 |
Why?
|
| Breast Neoplasms | 8 | 2024 | 2509 | 0.550 |
Why?
|
| Animals, Newborn | 5 | 2023 | 1010 | 0.540 |
Why?
|
| MicroRNAs | 1 | 2023 | 842 | 0.530 |
Why?
|
| Epithelial Cells | 11 | 2018 | 910 | 0.530 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 3 | 2005 | 35 | 0.510 |
Why?
|
| Estrogen Receptor alpha | 4 | 2020 | 468 | 0.490 |
Why?
|
| Endocrine Disruptors | 3 | 2024 | 52 | 0.470 |
Why?
|
| DNA Methylation | 6 | 2024 | 1004 | 0.460 |
Why?
|
| Signal Transduction | 10 | 2025 | 4542 | 0.460 |
Why?
|
| Serine | 1 | 2014 | 173 | 0.440 |
Why?
|
| Mycobacterium tuberculosis | 3 | 2024 | 378 | 0.440 |
Why?
|
| Enhancer Elements, Genetic | 5 | 2020 | 296 | 0.430 |
Why?
|
| Leiomyoma | 2 | 2024 | 83 | 0.420 |
Why?
|
| Epigenesis, Genetic | 8 | 2024 | 674 | 0.410 |
Why?
|
| Protein Array Analysis | 2 | 2022 | 101 | 0.370 |
Why?
|
| Progesterone | 6 | 2018 | 625 | 0.360 |
Why?
|
| Female | 35 | 2025 | 66553 | 0.350 |
Why?
|
| Microtubules | 2 | 2021 | 197 | 0.350 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2021 | 158 | 0.330 |
Why?
|
| Cell Line, Tumor | 8 | 2025 | 3338 | 0.320 |
Why?
|
| Mammary Tumor Virus, Mouse | 2 | 1999 | 106 | 0.310 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 2020 | 63 | 0.310 |
Why?
|
| Testis | 2 | 2021 | 411 | 0.310 |
Why?
|
| Receptors, Androgen | 2 | 2022 | 415 | 0.300 |
Why?
|
| Transforming Growth Factor beta | 3 | 2023 | 459 | 0.300 |
Why?
|
| Mice, Knockout | 8 | 2024 | 3753 | 0.300 |
Why?
|
| Epigenomics | 3 | 2024 | 164 | 0.300 |
Why?
|
| Lung | 4 | 2023 | 1491 | 0.300 |
Why?
|
| Milk Proteins | 3 | 2002 | 92 | 0.290 |
Why?
|
| Cell Proliferation | 8 | 2020 | 2304 | 0.280 |
Why?
|
| Oncogenes | 5 | 2020 | 169 | 0.270 |
Why?
|
| Gene Expression Profiling | 5 | 2025 | 1697 | 0.270 |
Why?
|
| Keratins | 1 | 2006 | 55 | 0.260 |
Why?
|
| Breast | 2 | 2018 | 216 | 0.260 |
Why?
|
| Morphogenesis | 2 | 2025 | 212 | 0.260 |
Why?
|
| Humans | 40 | 2025 | 124793 | 0.260 |
Why?
|
| Lipopolysaccharides | 2 | 2024 | 294 | 0.250 |
Why?
|
| Nodal Protein | 1 | 2025 | 16 | 0.250 |
Why?
|
| Gastrulation | 1 | 2025 | 17 | 0.250 |
Why?
|
| SMARCB1 Protein | 1 | 2025 | 38 | 0.240 |
Why?
|
| Trialkyltin Compounds | 1 | 2024 | 7 | 0.240 |
Why?
|
| Histones | 3 | 2022 | 534 | 0.240 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2024 | 28 | 0.240 |
Why?
|
| Transcription, Genetic | 5 | 2024 | 1704 | 0.230 |
Why?
|
| Citric Acid Cycle | 1 | 2024 | 47 | 0.230 |
Why?
|
| Ganglia, Spinal | 1 | 2024 | 71 | 0.230 |
Why?
|
| Neuralgia | 1 | 2024 | 45 | 0.230 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2025 | 127 | 0.230 |
Why?
|
| Estrogens | 4 | 2020 | 515 | 0.230 |
Why?
|
| Zebrafish Proteins | 1 | 2025 | 111 | 0.230 |
Why?
|
| Myometrium | 1 | 2024 | 47 | 0.230 |
Why?
|
| Sensory Receptor Cells | 1 | 2024 | 57 | 0.230 |
Why?
|
| Receptors, Prolactin | 2 | 2002 | 12 | 0.220 |
Why?
|
| Pharmacology, Clinical | 1 | 2023 | 5 | 0.220 |
Why?
|
| Immune Tolerance | 1 | 2024 | 145 | 0.220 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2025 | 1898 | 0.220 |
Why?
|
| Male | 14 | 2025 | 61283 | 0.210 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2020 | 133 | 0.210 |
Why?
|
| Uterine Neoplasms | 1 | 2024 | 107 | 0.210 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2023 | 48 | 0.210 |
Why?
|
| Extracellular Matrix | 1 | 2024 | 233 | 0.210 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 113 | 0.200 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2023 | 82 | 0.200 |
Why?
|
| Infant, Newborn | 4 | 2024 | 8182 | 0.200 |
Why?
|
| Zebrafish | 1 | 2025 | 388 | 0.200 |
Why?
|
| Apoptosis | 3 | 1998 | 1791 | 0.200 |
Why?
|
| Primary Graft Dysfunction | 1 | 2022 | 24 | 0.200 |
Why?
|
| STAT5 Transcription Factor | 5 | 2013 | 90 | 0.200 |
Why?
|
| Mammary Glands, Human | 1 | 2003 | 80 | 0.200 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2002 | 551 | 0.190 |
Why?
|
| DNA Transposable Elements | 1 | 2023 | 177 | 0.190 |
Why?
|
| Phosphorylation | 4 | 2024 | 1624 | 0.190 |
Why?
|
| Protective Factors | 1 | 2021 | 85 | 0.180 |
Why?
|
| Osteosarcoma | 1 | 2024 | 259 | 0.180 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2024 | 234 | 0.180 |
Why?
|
| Interleukin-6 | 2 | 2020 | 421 | 0.170 |
Why?
|
| Liver | 2 | 2024 | 1764 | 0.170 |
Why?
|
| Epididymis | 1 | 2020 | 54 | 0.170 |
Why?
|
| Reading | 1 | 2021 | 80 | 0.170 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2024 | 720 | 0.170 |
Why?
|
| Organotin Compounds | 1 | 2020 | 6 | 0.170 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2020 | 33 | 0.170 |
Why?
|
| RNA, Antisense | 1 | 2020 | 35 | 0.170 |
Why?
|
| Repressor Proteins | 1 | 2024 | 820 | 0.170 |
Why?
|
| Oxygen | 1 | 2023 | 555 | 0.160 |
Why?
|
| Bone Neoplasms | 1 | 2024 | 429 | 0.160 |
Why?
|
| Sex Factors | 1 | 2023 | 1285 | 0.160 |
Why?
|
| Urinary Tract Infections | 1 | 2023 | 301 | 0.160 |
Why?
|
| Glycoproteins | 2 | 1998 | 370 | 0.160 |
Why?
|
| Sex Characteristics | 1 | 2021 | 319 | 0.160 |
Why?
|
| Environmental Pollutants | 1 | 2020 | 69 | 0.160 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2020 | 246 | 0.160 |
Why?
|
| Intestinal Mucosa | 1 | 2024 | 775 | 0.160 |
Why?
|
| Tamoxifen | 1 | 2020 | 363 | 0.160 |
Why?
|
| Leukocytes | 1 | 2020 | 206 | 0.160 |
Why?
|
| Proto-Oncogenes | 1 | 1998 | 37 | 0.160 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 334 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2020 | 197 | 0.150 |
Why?
|
| Gene Expression | 3 | 2020 | 1570 | 0.150 |
Why?
|
| Lung Transplantation | 1 | 2022 | 320 | 0.150 |
Why?
|
| Ovary | 1 | 2021 | 381 | 0.150 |
Why?
|
| Pneumonia | 1 | 2022 | 326 | 0.150 |
Why?
|
| Actins | 1 | 2020 | 342 | 0.150 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2023 | 399 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 4 | 2024 | 1341 | 0.150 |
Why?
|
| Models, Biological | 3 | 2016 | 1461 | 0.150 |
Why?
|
| Transcriptional Activation | 4 | 2013 | 486 | 0.150 |
Why?
|
| Chromatin | 3 | 2022 | 555 | 0.150 |
Why?
|
| Receptors, Estrogen | 2 | 2018 | 796 | 0.150 |
Why?
|
| STAT3 Transcription Factor | 1 | 2020 | 221 | 0.150 |
Why?
|
| Antineoplastic Agents | 3 | 2016 | 1664 | 0.140 |
Why?
|
| Promyelocytic Leukemia Protein | 1 | 2017 | 12 | 0.140 |
Why?
|
| Genetic Engineering | 1 | 2018 | 163 | 0.140 |
Why?
|
| Proteomics | 1 | 2021 | 500 | 0.140 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 382 | 0.140 |
Why?
|
| RNA, Long Noncoding | 1 | 2020 | 211 | 0.140 |
Why?
|
| I-kappa B Kinase | 1 | 2017 | 61 | 0.140 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 1690 | 0.140 |
Why?
|
| Microbiota | 1 | 2022 | 390 | 0.140 |
Why?
|
| Prospective Studies | 2 | 2025 | 6137 | 0.140 |
Why?
|
| Homeodomain Proteins | 1 | 2020 | 546 | 0.130 |
Why?
|
| Membrane Proteins | 2 | 2020 | 1527 | 0.130 |
Why?
|
| Rats | 5 | 2023 | 3689 | 0.130 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2016 | 13 | 0.130 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2015 | 18 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2015 | 49 | 0.130 |
Why?
|
| Bevacizumab | 1 | 2016 | 63 | 0.130 |
Why?
|
| Virus Replication | 1 | 1999 | 611 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2017 | 554 | 0.120 |
Why?
|
| Cell Line | 7 | 2020 | 2771 | 0.120 |
Why?
|
| Protein Binding | 3 | 2016 | 1749 | 0.120 |
Why?
|
| Radiotherapy | 1 | 2016 | 136 | 0.120 |
Why?
|
| Anxiety | 1 | 2021 | 967 | 0.120 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2023 | 938 | 0.120 |
Why?
|
| DNA-Binding Proteins | 6 | 2002 | 2058 | 0.120 |
Why?
|
| Cell Division | 4 | 2003 | 782 | 0.110 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2020 | 538 | 0.110 |
Why?
|
| NF-kappa B | 1 | 1996 | 457 | 0.110 |
Why?
|
| Trans-Activators | 5 | 2002 | 808 | 0.110 |
Why?
|
| TATA-Box Binding Protein | 1 | 2013 | 30 | 0.110 |
Why?
|
| Cell Differentiation | 5 | 2024 | 1929 | 0.110 |
Why?
|
| Estrenes | 1 | 2013 | 21 | 0.110 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 2013 | 5 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2020 | 886 | 0.110 |
Why?
|
| Prostatic Neoplasms | 1 | 2022 | 1547 | 0.110 |
Why?
|
| RANK Ligand | 1 | 2013 | 52 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2022 | 356 | 0.100 |
Why?
|
| Disease Models, Animal | 5 | 2023 | 4357 | 0.100 |
Why?
|
| Models, Molecular | 1 | 2016 | 1075 | 0.100 |
Why?
|
| Mice, Transgenic | 3 | 2018 | 2410 | 0.100 |
Why?
|
| Quinestrol | 1 | 1992 | 1 | 0.100 |
Why?
|
| Endocrine Glands | 1 | 1992 | 10 | 0.100 |
Why?
|
| Protein Folding | 1 | 2013 | 218 | 0.100 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2013 | 241 | 0.100 |
Why?
|
| Prolactin | 3 | 2013 | 114 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 1604 | 0.100 |
Why?
|
| Glioblastoma | 1 | 2016 | 333 | 0.100 |
Why?
|
| Thyroid Gland | 1 | 1992 | 113 | 0.090 |
Why?
|
| Cellular Senescence | 2 | 2023 | 162 | 0.090 |
Why?
|
| Neurons | 1 | 2021 | 1965 | 0.090 |
Why?
|
| Adult | 4 | 2025 | 29471 | 0.090 |
Why?
|
| Caseins | 1 | 2011 | 62 | 0.090 |
Why?
|
| Phosphoproteins | 2 | 2003 | 404 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2025 | 1001 | 0.090 |
Why?
|
| Lactation | 1 | 1992 | 194 | 0.090 |
Why?
|
| Inflammation | 3 | 2022 | 1428 | 0.090 |
Why?
|
| Carcinogenesis | 2 | 2023 | 333 | 0.090 |
Why?
|
| Cell Cycle | 2 | 2020 | 615 | 0.090 |
Why?
|
| Protein Isoforms | 2 | 2018 | 412 | 0.080 |
Why?
|
| Middle Aged | 3 | 2025 | 26716 | 0.080 |
Why?
|
| Risk Factors | 2 | 2021 | 10272 | 0.080 |
Why?
|
| Estradiol | 2 | 2020 | 535 | 0.080 |
Why?
|
| Neoplasm Metastasis | 2 | 2020 | 667 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 2 | 2020 | 611 | 0.070 |
Why?
|
| Epithelium | 3 | 2018 | 362 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2013 | 756 | 0.070 |
Why?
|
| Aged | 1 | 2025 | 19691 | 0.070 |
Why?
|
| Base Sequence | 4 | 1999 | 3099 | 0.070 |
Why?
|
| Brain Neoplasms | 1 | 2016 | 1239 | 0.070 |
Why?
|
| Keratin-6 | 1 | 2006 | 13 | 0.070 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2017 | 247 | 0.070 |
Why?
|
| Binding Sites | 2 | 2019 | 1297 | 0.070 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2003 | 78 | 0.060 |
Why?
|
| Carrier Proteins | 2 | 2023 | 1026 | 0.060 |
Why?
|
| Cyclin E | 1 | 2005 | 30 | 0.060 |
Why?
|
| cdc25 Phosphatases | 1 | 2005 | 21 | 0.060 |
Why?
|
| HeLa Cells | 2 | 2015 | 809 | 0.060 |
Why?
|
| Gastrula | 1 | 2025 | 20 | 0.060 |
Why?
|
| Ki-67 Antigen | 1 | 2005 | 115 | 0.060 |
Why?
|
| Neural Plate | 1 | 2025 | 10 | 0.060 |
Why?
|
| Ectoderm | 1 | 2025 | 31 | 0.060 |
Why?
|
| Cyclin D1 | 1 | 2005 | 112 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 199 | 0.060 |
Why?
|
| Transcription Factors | 3 | 2023 | 2609 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2002 | 2825 | 0.060 |
Why?
|
| Receptors, Opioid, delta | 1 | 2024 | 12 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2020 | 701 | 0.060 |
Why?
|
| Mesoderm | 1 | 2025 | 113 | 0.060 |
Why?
|
| Body Patterning | 1 | 2025 | 124 | 0.060 |
Why?
|
| Succinic Acid | 1 | 2024 | 14 | 0.060 |
Why?
|
| Succinates | 1 | 2024 | 20 | 0.060 |
Why?
|
| Receptors, Steroid | 1 | 2006 | 275 | 0.060 |
Why?
|
| Embryo, Nonmammalian | 1 | 2025 | 144 | 0.060 |
Why?
|
| Receptors, Opioid, mu | 1 | 2024 | 30 | 0.060 |
Why?
|
| Hormones | 1 | 2005 | 187 | 0.060 |
Why?
|
| Cattle | 1 | 2006 | 566 | 0.060 |
Why?
|
| Everolimus | 1 | 2024 | 46 | 0.060 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2024 | 37 | 0.060 |
Why?
|
| Cell Nucleus | 3 | 2002 | 677 | 0.060 |
Why?
|
| Serum Response Factor | 1 | 2024 | 29 | 0.060 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2024 | 35 | 0.060 |
Why?
|
| Mannose | 1 | 2023 | 20 | 0.060 |
Why?
|
| Promegestone | 2 | 2015 | 31 | 0.060 |
Why?
|
| Enterocytes | 1 | 2024 | 75 | 0.060 |
Why?
|
| Jejunum | 1 | 2024 | 128 | 0.050 |
Why?
|
| Phenotype | 3 | 2021 | 4260 | 0.050 |
Why?
|
| Urothelium | 1 | 2023 | 60 | 0.050 |
Why?
|
| Carcinogens | 1 | 2023 | 153 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2023 | 162 | 0.050 |
Why?
|
| Hedgehog Proteins | 1 | 2024 | 189 | 0.050 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2002 | 8 | 0.050 |
Why?
|
| Cornified Envelope Proline-Rich Proteins | 1 | 2002 | 19 | 0.050 |
Why?
|
| Phosphotyrosine | 1 | 2002 | 23 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2005 | 1110 | 0.050 |
Why?
|
| Disease Progression | 2 | 2020 | 2052 | 0.050 |
Why?
|
| Dimerization | 1 | 2003 | 144 | 0.050 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2002 | 40 | 0.050 |
Why?
|
| Chemokine CXCL10 | 1 | 2022 | 53 | 0.050 |
Why?
|
| Cell Cycle Proteins | 2 | 2020 | 647 | 0.050 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2022 | 46 | 0.050 |
Why?
|
| Chemokine CCL5 | 1 | 2022 | 54 | 0.050 |
Why?
|
| Genome-Wide Association Study | 2 | 2020 | 1674 | 0.050 |
Why?
|
| Progestins | 2 | 2013 | 48 | 0.050 |
Why?
|
| Urinary Bladder | 1 | 2023 | 245 | 0.050 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2022 | 53 | 0.050 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2022 | 96 | 0.050 |
Why?
|
| Guinea Pigs | 1 | 2022 | 167 | 0.050 |
Why?
|
| Protein Precursors | 1 | 2002 | 153 | 0.050 |
Why?
|
| In Situ Hybridization | 1 | 2002 | 470 | 0.050 |
Why?
|
| Ligands | 1 | 2023 | 536 | 0.050 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2003 | 139 | 0.050 |
Why?
|
| CpG Islands | 1 | 2023 | 323 | 0.050 |
Why?
|
| Interleukin-8 | 1 | 2022 | 209 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2024 | 372 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2024 | 350 | 0.050 |
Why?
|
| Organoids | 1 | 2024 | 284 | 0.050 |
Why?
|
| Quantitative Trait Loci | 1 | 2023 | 284 | 0.050 |
Why?
|
| Pregnancy, Animal | 1 | 2001 | 76 | 0.050 |
Why?
|
| Immunity | 1 | 2022 | 191 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2003 | 348 | 0.050 |
Why?
|
| Prognosis | 2 | 2024 | 4607 | 0.050 |
Why?
|
| Methylation | 1 | 2021 | 224 | 0.050 |
Why?
|
| Quality Control | 1 | 2021 | 119 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2002 | 211 | 0.040 |
Why?
|
| Dysbiosis | 1 | 2022 | 122 | 0.040 |
Why?
|
| Dihydrotestosterone | 1 | 2020 | 67 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2023 | 492 | 0.040 |
Why?
|
| Autophagy-Related Proteins | 1 | 2020 | 35 | 0.040 |
Why?
|
| RNA, Catalytic | 1 | 2000 | 15 | 0.040 |
Why?
|
| Aromatase Inhibitors | 1 | 2020 | 77 | 0.040 |
Why?
|
| Receptors, Growth Factor | 1 | 2000 | 34 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2021 | 121 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 125 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2023 | 389 | 0.040 |
Why?
|
| Dihydroergotamine | 1 | 2020 | 10 | 0.040 |
Why?
|
| DNA Damage | 1 | 2023 | 515 | 0.040 |
Why?
|
| Biological Transport | 2 | 2002 | 348 | 0.040 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2020 | 39 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2021 | 178 | 0.040 |
Why?
|
| DNA Repair | 1 | 2023 | 587 | 0.040 |
Why?
|
| Toxicity Tests | 1 | 2020 | 35 | 0.040 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2020 | 52 | 0.040 |
Why?
|
| Transfection | 2 | 1998 | 1069 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2022 | 867 | 0.040 |
Why?
|
| Metabolome | 1 | 2022 | 294 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2022 | 359 | 0.040 |
Why?
|
| DNA Footprinting | 1 | 1999 | 14 | 0.040 |
Why?
|
| Tropism | 1 | 1999 | 9 | 0.040 |
Why?
|
| Gene-Environment Interaction | 1 | 2020 | 122 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 1998 | 173 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1999 | 49 | 0.040 |
Why?
|
| Pyridines | 1 | 2020 | 230 | 0.040 |
Why?
|
| Fibroblast Growth Factor 3 | 1 | 1998 | 10 | 0.040 |
Why?
|
| Retroviridae Infections | 1 | 1998 | 10 | 0.040 |
Why?
|
| Proviruses | 1 | 1998 | 17 | 0.040 |
Why?
|
| Terminal Repeat Sequences | 1 | 1998 | 18 | 0.040 |
Why?
|
| RNA | 1 | 2022 | 568 | 0.040 |
Why?
|
| Neuregulins | 1 | 1998 | 3 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2019 | 238 | 0.040 |
Why?
|
| Neuregulin-1 | 1 | 1998 | 13 | 0.040 |
Why?
|
| Piperazines | 1 | 2020 | 238 | 0.040 |
Why?
|
| Virus Integration | 1 | 1998 | 42 | 0.040 |
Why?
|
| Antitubercular Agents | 1 | 2021 | 247 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2018 | 88 | 0.040 |
Why?
|
| Cellular Reprogramming | 1 | 2020 | 116 | 0.040 |
Why?
|
| Adiposity | 1 | 2020 | 191 | 0.040 |
Why?
|
| Reproduction | 1 | 2020 | 239 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2023 | 986 | 0.040 |
Why?
|
| Cricetinae | 1 | 1998 | 414 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1999 | 369 | 0.040 |
Why?
|
| Stem Cells | 1 | 2003 | 702 | 0.040 |
Why?
|
| DNA Primers | 1 | 1999 | 660 | 0.040 |
Why?
|
| Tumor Virus Infections | 1 | 1998 | 133 | 0.040 |
Why?
|
| Pregnancy | 5 | 2013 | 7172 | 0.040 |
Why?
|
| Steroids | 1 | 1998 | 203 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 1998 | 153 | 0.040 |
Why?
|
| Proteins | 2 | 2021 | 1046 | 0.040 |
Why?
|
| Dexamethasone | 1 | 1999 | 275 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 510 | 0.030 |
Why?
|
| Autophagy | 1 | 2020 | 395 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 1998 | 574 | 0.030 |
Why?
|
| Mutation | 2 | 2020 | 5811 | 0.030 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 256 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2017 | 222 | 0.030 |
Why?
|
| Cytokines | 1 | 2022 | 1290 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 285 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 530 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2022 | 814 | 0.030 |
Why?
|
| Models, Animal | 1 | 2018 | 465 | 0.030 |
Why?
|
| Cell Movement | 1 | 2020 | 835 | 0.030 |
Why?
|
| Gonanes | 1 | 2015 | 16 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 545 | 0.030 |
Why?
|
| Chromones | 1 | 2015 | 22 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2017 | 571 | 0.030 |
Why?
|
| Culture Media | 1 | 1996 | 182 | 0.030 |
Why?
|
| DNA Modification Methylases | 1 | 2016 | 44 | 0.030 |
Why?
|
| Mifepristone | 1 | 2015 | 135 | 0.030 |
Why?
|
| Morpholines | 1 | 2015 | 57 | 0.030 |
Why?
|
| Dacarbazine | 1 | 2016 | 86 | 0.030 |
Why?
|
| Mediator Complex | 1 | 2015 | 52 | 0.030 |
Why?
|
| Purines | 1 | 2015 | 114 | 0.030 |
Why?
|
| DNA | 2 | 1998 | 1600 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2013 | 2704 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 1998 | 940 | 0.030 |
Why?
|
| Avian Proteins | 1 | 1994 | 12 | 0.030 |
Why?
|
| Acetyltransferases | 1 | 1994 | 90 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2017 | 467 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 869 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 1090 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 868 | 0.030 |
Why?
|
| Halogenation | 1 | 2013 | 5 | 0.030 |
Why?
|
| Biomarkers | 1 | 2022 | 3063 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2022 | 4783 | 0.030 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1992 | 12 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 2142 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2013 | 238 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 1999 | 1272 | 0.030 |
Why?
|
| Karyometry | 1 | 1992 | 1 | 0.030 |
Why?
|
| Rats, Inbred Strains | 1 | 1992 | 234 | 0.020 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 2 | 2002 | 6 | 0.020 |
Why?
|
| Point Mutation | 1 | 2013 | 348 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 1393 | 0.020 |
Why?
|
| Chromosomes | 1 | 1992 | 199 | 0.020 |
Why?
|
| Genomics | 1 | 2019 | 1490 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2013 | 528 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 1008 | 0.020 |
Why?
|
| Embryo Implantation | 1 | 2013 | 234 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2011 | 129 | 0.020 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2011 | 122 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2011 | 219 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 1229 | 0.020 |
Why?
|
| Brain | 1 | 2021 | 3008 | 0.020 |
Why?
|
| Mice, Nude | 2 | 2002 | 710 | 0.020 |
Why?
|
| Infant | 1 | 2024 | 12482 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 2000 | 1066 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 3061 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2022 | 16299 | 0.010 |
Why?
|
| Child | 1 | 2024 | 24453 | 0.010 |
Why?
|
| Estrous Cycle | 1 | 2003 | 35 | 0.010 |
Why?
|
| Chickens | 2 | 1994 | 638 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2003 | 314 | 0.010 |
Why?
|
| Ovariectomy | 1 | 2003 | 183 | 0.010 |
Why?
|
| Solute Carrier Family 12, Member 2 | 1 | 2001 | 7 | 0.010 |
Why?
|
| Time Factors | 1 | 1992 | 6309 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 8987 | 0.010 |
Why?
|
| Connexins | 1 | 2001 | 59 | 0.010 |
Why?
|
| Growth Hormone | 1 | 2001 | 150 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2001 | 122 | 0.010 |
Why?
|
| Janus Kinase 2 | 1 | 2002 | 134 | 0.010 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2000 | 3 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2003 | 471 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 12342 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2000 | 255 | 0.010 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2000 | 93 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2000 | 374 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1994 | 3881 | 0.010 |
Why?
|
| Caspases | 1 | 1998 | 162 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2000 | 1691 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 1994 | 7 | 0.010 |
Why?
|
| Muramidase | 1 | 1994 | 93 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1998 | 724 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2000 | 566 | 0.010 |
Why?
|
| Oncogene Proteins v-myb | 1 | 1992 | 4 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1992 | 152 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1992 | 186 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1992 | 658 | 0.010 |
Why?
|